Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Share-based Compensation (2016 - 2024)

Historic Share-based Compensation for Sunshine Biopharma (SBFMW) over the last 9 years, with Q1 2024 value amounting to $12000.0.

  • Sunshine Biopharma's Share-based Compensation changed N/A to $12000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $12000.0 for FY2024, which is N/A changed from last year.
  • As of Q1 2024, Sunshine Biopharma's Share-based Compensation stood at $12000.0.
  • Over the past 5 years, Sunshine Biopharma's Share-based Compensation peaked at $918000.0 during Q1 2021, and registered a low of $12000.0 during Q1 2024.
  • Over the past 3 years, Sunshine Biopharma's median Share-based Compensation value was $50000.0 (recorded in 2020), while the average stood at $326666.7.